Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yuji Kunita"'
Autor:
Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki, Seigo Kinuya
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 663 (2020)
123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. 131I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy 131I-mIBG scintigra
Externí odkaz:
https://doaj.org/article/66f78a23b1f946638aa7f886539e7062
Publikováno v:
Annals of Nuclear Medicine. 36:674-683
Purpose Selecting patients with coronary multivessel disease (MVD) or no stenosis using myocardial perfusion imaging (MPI) is challenging. We aimed to create a model to predict MVD using a combination of quantitative MPI values and background factors
Autor:
Norihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Aki Takata, Tomo Hiromasa, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Hiroshi Mori, Shintaro Saito, Kenichi Nakajima, Seigo Kinuya
Publikováno v:
Endocrine journal.
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy (RIT) in a University Hospit
Autor:
Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Tomo Hiromasa, Hiroshi Mori, Kenji Hirata, Shiro Watanabe, Tetsuya Higuchi, Hiroyasu Tomonaga, Seigo Kinuya
Publikováno v:
Annals of Nuclear Medicine. 36:267-278
Objective In this phase II study, we aimed to investigate the efficacy and safety of single-dose [131I]meta-iodobenzylguanidine (131I-mIBG) therapy in patients with refractory pheochromocytoma and paraganglioma (PPGL). Patients and methods This study
Autor:
Seigo Kinuya, Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Shintaro Saito, Anri Inaki, Yuji Kunita, Takafumi Yamase, Satoru Watanabe, Norihito Akatani, Daiki Kayano
Publikováno v:
Annals of Nuclear Medicine. 36:61-69
OBJECTIVE Given the rarity of refractory pheochromocytoma and paraganglioma (PPGL), outcomes and prognostic factors after 131I-metaiodobenzylguanidine (131I-mIBG) treatment still remain unclear. Therefore, this study evaluated whether baseline charac
Autor:
Norihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Aki Takata, Tomo Hiromasa, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Hiroshi Mori, Shintaro Saito, Kenichi Nakajima, Seigo Kinuya
Publikováno v:
Endocrine Journal; 2023, Vol. 70 Issue 3, p315-322, 8p
Autor:
Hiroshi Mori, Rie Kuroda, Raita Araki, Seigo Kinuya, Taizo Wada, Anri Inaki, Takafumi Yamase, Satoru Watanabe, Toshihiro Fujiki, Norihito Akatani, Shintaro Saito, Ryosei Nishimura, Hiroshi Wakabayashi, Yuji Kunita, Yasuhiro Ikawa, Tomo Hiromasa, Daiki Kayano
Publikováno v:
Annals of Nuclear Medicine. 34:840-846
Children with relapsed neuroblastoma have a poor prognosis despite modern multimodality therapy. Novel and more effective therapeutic strategies are required for relapsed neuroblastoma. We retrospectively examined the utility of consolidation therapy
Autor:
Tomo, Hiromasa, Hiroshi, Wakabayashi, Daiki, Kayano, Anri, Inaki, Satoru, Watanabe, Hiroshi, Mori, Norihito, Akatani, Takafumi, Yamase, Yuji, Kunita, Shintaro, Saito, Seigo, Kinuya
Publikováno v:
Annals of nuclear medicine. 36(1)
Given the rarity of refractory pheochromocytoma and paraganglioma (PPGL), outcomes and prognostic factors afterAll patients [n = 59 (male/female = 35/24), median age; 49.3 years] with refractory PPGL who receivedThroughout the follow-up period, 18 pa
Autor:
Hiroshi, Wakabayashi, Daiki, Kayano, Anri, Inaki, Raita, Araki, Rie, Kuroda, Yasuhiro, Ikawa, Toshihiro, Fujiki, Norihito, Akatani, Takafumi, Yamase, Satoru, Watanabe, Tomo, Hiromasa, Yuji, Kunita, Hiroshi, Mori, Shintaro, Saito, Ryosei, Nishimura, Taizo, Wada, Seigo, Kinuya
Publikováno v:
Annals of nuclear medicine. 34(11)
Children with relapsed neuroblastoma have a poor prognosis despite modern multimodality therapy. Novel and more effective therapeutic strategies are required for relapsed neuroblastoma. We retrospectively examined the utility of consolidation therapy
Autor:
Daiki, Kayano, Hiroshi, Wakabayashi, Kenichi, Nakajima, Rie, Kuroda, Satoru, Watanabe, Anri, Inaki, Ayane, Toratani, Norihito, Akatani, Takafumi, Yamase, Yuji, Kunita, Tomo, Hiromasa, Aki, Takata, Hiroshi, Mori, Shintaro, Saito, Raita, Araki, Junichi, Taki, Seigo, Kinuya
Publikováno v:
Annals of nuclear medicine. 34(6)
The aim of the study was to investigate the outcomes and prognostic factors of high-doseWe retrospectively analyzed 20 patients with refractory or relapsed high-risk NBL who underwentIn 19 patients with complete follow-up data, the median age at firs